chr1-9245189-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_004285.4(H6PD):c.255C>T(p.Ser85=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00263 in 1,614,244 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0020 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0027 ( 27 hom. )
Consequence
H6PD
NM_004285.4 synonymous
NM_004285.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.76
Genes affected
H6PD (HGNC:4795): (hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase) There are 2 forms of glucose-6-phosphate dehydrogenase. G form is X-linked and H form, encoded by this gene, is autosomally linked. This H form shows activity with other hexose-6-phosphates, especially galactose-6-phosphate, whereas the G form is specific for glucose-6-phosphate. Both forms are present in most tissues, but H form is not found in red cells. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 1-9245189-C-T is Benign according to our data. Variant chr1-9245189-C-T is described in ClinVar as [Benign]. Clinvar id is 730928.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-9245189-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.76 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00197 (300/152354) while in subpopulation SAS AF= 0.0188 (91/4832). AF 95% confidence interval is 0.0157. There are 2 homozygotes in gnomad4. There are 175 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
H6PD | NM_004285.4 | c.255C>T | p.Ser85= | synonymous_variant | 2/5 | ENST00000377403.7 | NP_004276.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
H6PD | ENST00000377403.7 | c.255C>T | p.Ser85= | synonymous_variant | 2/5 | 1 | NM_004285.4 | ENSP00000366620 | P1 | |
H6PD | ENST00000602477.1 | c.288C>T | p.Ser96= | synonymous_variant | 2/5 | 1 | ENSP00000473348 |
Frequencies
GnomAD3 genomes AF: 0.00197 AC: 300AN: 152236Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
300
AN:
152236
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00368 AC: 926AN: 251396Hom.: 10 AF XY: 0.00436 AC XY: 593AN XY: 135886
GnomAD3 exomes
AF:
AC:
926
AN:
251396
Hom.:
AF XY:
AC XY:
593
AN XY:
135886
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00270 AC: 3942AN: 1461890Hom.: 27 Cov.: 34 AF XY: 0.00312 AC XY: 2271AN XY: 727246
GnomAD4 exome
AF:
AC:
3942
AN:
1461890
Hom.:
Cov.:
34
AF XY:
AC XY:
2271
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00197 AC: 300AN: 152354Hom.: 2 Cov.: 33 AF XY: 0.00235 AC XY: 175AN XY: 74500
GnomAD4 genome
AF:
AC:
300
AN:
152354
Hom.:
Cov.:
33
AF XY:
AC XY:
175
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at